Stock

Processa Pharmaceuticals, Inc.

000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol PCSA:xnas
Currency USD
united-states
NASDAQ (Small cap)
15 minutes delayed
Data provided by Cboe Global Markets
This information is not currently available for this instrument. Refresh the page or try again later.

Chart

This information is not currently available for this instrument. Refresh the page or try again later.
Open account to access more charting and analysis tools

Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer

About Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

Sector Healthcare
Industry Oncology Biopharmaceuticals
Market Cap 0.0195858bn
Data provided by FactSet Research Systems / Morningstar

Frequently asked questions

To buy Processa Pharmaceuticals, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Processa Pharmaceuticals, Inc. by name or ticker, choose the number of shares, and place your order.

The ticker symbol for Processa Pharmaceuticals, Inc. is PCSA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.

Processa Pharmaceuticals, Inc. has its primary listing on NASDAQ (Small cap). You can trade Processa Pharmaceuticals, Inc. with a Saxo account, alongside thousands of other stocks worldwide.

Yes, Processa Pharmaceuticals, Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Processa Pharmaceuticals, Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.

Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Processa Pharmaceuticals, Inc..

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900 Hellerup
Denmark

Contact Saxo

Select region

International
International

All trading and investing comes with risk, including but not limited to the potential to lose your entire invested amount.

Information on our international website (as selected from the globe drop-down) can be accessed worldwide and relates to Saxo Bank A/S as the parent company of the Saxo Bank Group. Any mention of the Saxo Bank Group refers to the overall organisation, including subsidiaries and branches under Saxo Bank A/S. Client agreements are made with the relevant Saxo entity based on your country of residence and are governed by the applicable laws of that entity's jurisdiction.

Apple and the Apple logo are trademarks of Apple Inc., registered in the US and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.